Evidence map›Paper›PMID 25391456›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2015

CRY1, CRY2 and PRKCDBP genetic variants in metabolic syndrome.

Leena Kovanen, Kati Donner, Mari Kaunisto, Timo Partonen

Open access · bronzeAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Targeting Cryptochromes in Chronic Diseases.Cell biology international · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. A wrinkle in time: circadian biology in pulmonary vascular health and disease.American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  14. Review
  15. Article
  16. Sex Differences in Circadian Clock Genes and Myocardial Infarction Susceptibility.Journal of cardiovascular development and disease · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Leena KovanenDepartment of Mental Health and Substance Abuse Services, National Institute for Health and Welfare (THL), Helsinki, Finland.
Kati DonnerInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Mari Kaunisto1] Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland [2] Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Timo PartonenDepartment of Mental Health and Substance Abuse Services, National Institute for Health and Welfare (THL), Helsinki, Finland.
Finnish Institute for Health and Welfare · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The circadian clock affects metabolic cycles, and there is a link between circadian clock genes and metabolic syndrome. Therefore, we wanted to investigate whether variants of the core circadian clock genes, cryptochrome circadian clocks 1 and 2 (CRY1 and CRY2), or those of protein kinase C, delta binding protein (PRKCDBP), which regulate the interactions and abundance of dimers of the period and cryptochrome proteins, are associated with metabolic syndrome or its components. The association of 48 single-nucleotide polymorphisms (SNPs) from CRY1, CRY2 and PRKCDBP genes with metabolic disorder or its components was analyzed in a sample of 5910 individuals. Genotyping was performed using the Sequenom MassARRAY system. SNPs and haplotypes were analyzed using linear or logistic regression with additive models controlling for age and sex. Continuous phenotypes were permuted 10,000 times. False discovery rate q-values were calculated to correct for multiple testing. Overall, CRY1 and CRY2 variants showed nominal association with the metabolic syndrome components, hypertension and triglyceride levels, and one CRY2 variant had an association with metabolic syndrome, although none of these associations yielded significant q-values. However, the haplotype analysis of these variants supported the association of CRY1 with arterial hypertension and elevated blood pressure. Further studies are warranted regarding the role of CRY1 in cardiovascular diseases.

Indexed as

AdultAgedAged, 80 and overCryptochromesFemaleGenetic VariationGenotypeHaplotypesHumansHypertensionIntracellular Signaling Peptides and ProteinsMaleMetabolic SyndromeMiddle AgedPhenotypePolymorphism, Single NucleotideCAVIN3 protein, humanCRY1 protein, humanCRY2 protein, humanCryptochromesIntracellular Signaling Peptides and Proteins

Identifiers

PMID25391456
OpenAlexW2009828071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.